Figure 5 | Genetics in Medicine

Figure 5

From: Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity

Figure 5

Comparison of genetic testing costs and estimated clinical screening costs when genetic testing is used or not used for determining risk status in unaffected family members. These data are based on actual numbers of unaffected family members tested over a 9-year period. Medical costs are conservatively estimated using the Medicare fee schedule.

Back to article page